Phreesia Newsroom

Phreesia (PHR) Receives a Buy From J.P. Morgan

TipRanksDec 18 20:08

RBC Capital Sticks to Its Hold Rating for Phreesia (PHR)

TipRanksDec 13 09:53

Analysts Offer Insights on Healthcare Companies: Pharming Group (OtherPHGUF) and Phreesia (PHR)

TipRanksDec 13 09:53

Truist Financial Maintains Phreesia(PHR.US) With Buy Rating, Announces Target Price $34

Futu NewsDec 11 23:31

Phreesia Price Target Raised to $34.00/Share From $31.00 by Truist Securities

Dow JonesDec 11 22:10

Phreesia Is Maintained at Buy by Truist Securities

Dow JonesDec 11 22:10

Truist Financial Initiates Phreesia(PHR.US) With Buy Rating, Announces Target Price $34

Futu NewsDec 11 21:32

A Quick Look at Today's Ratings for Phreesia(PHR.US), With a Forecast Between $28 to $30

Futu NewsDec 11 21:00

Baird Maintains Outperform on Phreesia, Lowers Price Target to $30

BenzingaDec 11 20:34

A Quick Look at Today's Ratings for Phreesia(PHR.US), With a Forecast Between $29 to $34

Futu NewsDec 10 21:01

Optimistic Buy Rating for Phreesia: Margin Expansion, Strategic Growth, and Ambitious Profit Goals Drive Positive Outlook

TipRanksDec 10 19:30

Phreesia Analyst Ratings

BenzingaDec 10 19:23

Needham Reiterates Buy on Phreesia, Maintains $29 Price Target

BenzingaDec 10 19:23

Truist Financial Maintains Phreesia(PHR.US) With Buy Rating

Futu NewsDec 6 01:35

Analysts Offer Insights on Healthcare Companies: Phreesia (PHR), Larimar Therapeutics (LRMR) and Merus (MRUS)

TipRanksDec 6 01:28

CCORF Maintains Phreesia(PHR.US) With Buy Rating, Maintains Target Price $34

Futu NewsDec 3 21:31

D.A. Davidson Maintains Phreesia(PHR.US) With Buy Rating, Announces Target Price $32

Futu NewsNov 30 00:32

Phreesia's Strong Growth Prospects and Strategic Financial Position Justify Buy Rating

TipRanksNov 29 23:56

Barclays Maintains Phreesia(PHR.US) With Buy Rating, Maintains Target Price $29

Futu NewsOct 2 16:32

RBC Capital Maintains Phreesia(PHR.US) With Hold Rating, Maintains Target Price $23

Futu NewsSep 27 19:31